Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ploia, Cristinaa; 1 | Antoniou, Xanthia; 1 | Sclip, Alessandraa | Grande, Valentinaa; d | Cardinetti, Danielea | Colombo, Alessioa; 2 | Canu, Nadiab | Benussi, Luisac | Ghidoni, Robertac | Forloni, Gianluigia | Borsello, Tizianaa; *
Affiliations: [a] Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy | [b] Dipartimento di Neuroscienze, Università di Tor Vergata, Rome, Italy CNR, Rome, Italy | [c] Proteomics Unit NeuroBioGen Lab-Memory Clinic, IRCCS Centro S. Giovanni di Dio-Fatebenefratelli, Brescia, Italy | [d] NICO, Scientific Institute of the Cavalieri-Ottolenghi Foundation Neuroscience Institute of Turin, Orbassano (To), Italy
Correspondence: [*] Correspondence to: Tiziana Borsello, Neuronal Death and Neuroprotection Laboratory, Neuroscience Department, Istituto di Ricerche Farmacologiche “Mario Negri”, Via La Masa 19, 20156 Milano, Italy. Tel.: +39 02 39014469/39014592; Fax: +39 02 3546277; E-mail: tiziana.borsello@marionegri.it.
Note: [1] These two authors contributed equally to this work.
Note: [2] Present Address: DZNE - German Center for Neurodegenerative Diseases, Schillerstrasse 44, 80336 Munich, Germany.
Abstract: Alzheimer's disease (AD) is a major clinical concern, and the search for new molecules to combat disease progression remains important. One of the major hallmarks in AD pathogenesis is the hyperphosphorylation of tau and subsequent formation of neurofibrillary tangles. Several kinases are involved in this process. Amongst them, c-Jun N-terminal kinases (JNKs) are activated in AD brains and are also associated with the development of amyloid plaques. This study was designed to investigate the contribution of JNK in tau hyperphosphorylation and whether it may represent a potential therapeutic target for the fight against AD. The specific inhibition of JNK by the cell permeable peptide D-JNKI-1 led to a reduction of p-tau at S202/T205 and S422, two established target sites of JNK, in rat neuronal cultures and in human fibroblasts cultures. Similarly, D-JNKI-1 reduced p-tau at S202/T205 in an in vivo model of AD (TgCRND8 mice). Our findings support the fundamental role of JNK in the regulation of tau hyperphosphorylation and subsequently in AD pathogenesis.
Keywords: Alzheimer's disease, D-JNKI-1, JNK mitogen-activated protein kinases, phosphorylation, tau protein
DOI: 10.3233/JAD-2011-110320
Journal: Journal of Alzheimer's Disease, vol. 26, no. 2, pp. 315-329, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl